Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,915 | 15,508 | 16,821 | 23,872 | 8,083 |
| Marketable Securities | 61,146 | 36,144 | 57,328 | 104,280 | 190,838 |
| Other current assets | 2,003 | 0 | 723 | 154 | 1,089 |
| TOTAL | $111,713 | $55,757 | $88,772 | $132,458 | $205,145 |
| Non-Current Assets | |||||
| PPE Net | 72,541 | 60,501 | 76,885 | 76,726 | 18,906 |
| Investments And Advances | 8,799 | 10,750 | 14,201 | 38,100 | 87,571 |
| Intangibles | 1,463 | 0 | 565 | 2,826 | 5,086 |
| Other Non-Current Assets | 26,865 | 16,115 | 1,527 | 330 | 788 |
| TOTAL | $109,668 | $87,366 | $93,178 | $117,982 | $112,351 |
| Total Assets | $221,381 | $143,123 | $181,950 | $250,440 | $317,496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,348 | 2,235 | 4,489 | 8,228 | 5,798 |
| Accrued Expenses | 36,771 | 5,343 | 21,104 | 11,267 | 5,864 |
| Other current liabilities | N/A | 775 | 1,667 | 1,373 | 891 |
| TOTAL | $68,134 | $11,559 | $27,260 | $20,868 | $12,553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 254,353 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 19,550 | 13,266 | 0 | 5,164 | 5,891 |
| TOTAL | $271,737 | $10,885 | $8,684 | $10,728 | $11,525 |
| Total Liabilities | $339,871 | $22,444 | $35,944 | $31,596 | $24,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,345 | 98,483 | 79,088 | 79,032 | 82,297 |
| Common Shares | 38 | 10 | 8 | 8 | 8 |
| Retained earnings | -1,615,131 | -662,191 | -594,981 | -498,713 | -387,063 |
| Other shareholders' equity | 1,440 | -105 | -267 | -381 | -284 |
| TOTAL | $-118,490 | $120,679 | $146,006 | $218,844 | $293,418 |
| Total Liabilities And Equity | $221,381 | $143,123 | $181,950 | $250,440 | $317,496 |